IRTC · iRhythm Holdings, Inc.
$121.93
+0.54% last session
End-of-day data · close of 2026-10-26
Market cap
$4B
Enterprise value
$4B
Trailing P/E
—
Forward P/E
97.9
Dividend yield
0.0%
Beta
1.46
Avg volume
1M
Employees
2K
Daily Change %
0.54%
5 Days Change
1.91%
10 Days Change
12.21%
30 Days Change
10.46%
60 Days Change
1.40%
Month to Day Change
9.80%
Year to Day Change
-31.28%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — IRTC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-16
Latest call per bank · past 12 months
Wells Fargo
Overweight$150
+23.0% vs priceBank of America
Buy$180
+47.6% vs priceCitigroup
Buy$157
+28.8% vs priceJP Morgan
Overweight$175
+43.5% vs priceGoldman Sachs
Neutral$147
+20.6% vs priceMorgan Stanley
Overweight$205
+68.1% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-16 | Piper Sandler | Initiates | Overweight | $0.00 → $160 |
| 2026-10-06 | Wells Fargo | Maintains | Overweight | $168 → $150 |
| 2026-10-06 | Freedom Capital Markets | Maintains | Buy | $190 |
| 2026-10-05 | Needham | Maintains | Buy | $192 → $194 |
| 2026-08-18 | Wells Fargo | Maintains | Overweight | $180 → $168 |
| 2026-08-10 | Truist Securities | Maintains | Buy | $160 → $168 |
| 2026-08-07 | Wells Fargo | Maintains | Overweight | $180 → $168 |
| 2026-08-07 | Needham | Maintains | Buy | $255 → $192 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-26
- neutral: RSI (14): RSI is 67 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 6.2% above the 50-day MA ($114.76).
- bearish: Price vs 200-day MA: Trading 1.1% below the 200-day MA ($123.22).
- bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- bullish: MACD (12,26,9): MACD histogram is positive (+2.00) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($101.79) and high ($189.25).
IRTC Price Chart
Loading chart for IRTC…
Fundamentals
About iRhythm Holdings, Inc.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
More in Medical Devices
ABT
Abbott Laboratories
$181B -14.2% YTD
MDT
Medtronic plc.
$121B 1.2% YTD
SYK
Stryker Corporation
$117B -12.2% YTD
BSX
Boston Scientific Corporation
$66B -52.2% YTD
EW
Edwards Lifesciences Corporatio
$52B 6.2% YTD
GEHC
GE HealthCare Technologies Inc.
$33B -12.1% YTD
DXCM
DexCom, Inc.
$30B 18.4% YTD
PHG
Koninklijke Philips N.V. NY Reg
$26B 1.9% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.